Press release
Patented Drugs Market Expected to Reach $1,456.5 Billion by 2032
Patented Drugs Market
๐๐ข๐ฌ๐ญ ๐จ๐ ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ :
F. Hoffmann-La Roche AG, AbbVie Inc., Novartis AG, Bayer AG, Amgen Inc., Johnson & Johnson, Biogen, Pfizer Inc., AstraZeneca plc, Astellas Pharma Inc.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ https://www.alliedmarketresearch.com/request-sample/111477
On the basis of dosage form, the liquid segment dominated the market in 2022, and is the fastest growing segment during the forecast period. This is attributed to easy availability and accessibility of liquid patented drugs and increase in product approvals for liquid drug products.
On the basis of indication, the cancer segment held the highest patented drugs market share in 2022. This is attributed to increase in prevalence of cancer and development of novel cancer treatment during the forecast period. However, the others segment is expected to register fastest growth in the patented drugs market forecast period, owing to increase in R&D activities to develop new treatments for rare diseases and Parkinson's disease.
On the basis of distribution channel, the drug stores and retail pharmacies segment dominated the global market in 2022 and is the fastest growing segment during the forecast period, owing to easy availability of patented drugs through drugs stores and increase in sale of patented drugs.
Region wise, North America held the highest patented drugs market share in 2022, and is expected to maintain its lead during the forecast period owing to increase in prevalence of chronic diseases, rise in adoption of patented drugs, easy accessibility of medications, and strong presence of market players. However, Asia-Pacific is expected to exhibit the fastest growth during the forecast period, owing to rise in patent application filing by Japan and China, increase in prevalence of diabetes, and development of pharmaceutical industry.
๐ ๐จ๐ซ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ https://www.alliedmarketresearch.com/purchase-enquiry/111477
The patented drugs market analysis is segmented on the basis of dosage form, indication, distribution channel, and region. On the basis of dosage form, the market is classified into solid drug product, liquid drug product, and others. On the basis of indication, the market is categorized into cardiovascular diseases, cancer, autoimmune diseases, and others. On the basis of distribution channel, the market is segmented into hospital pharmacies, drug stores and retail pharmacies, and online pharmacies.
๐๐๐๐๐ ๐๐๐๐๐๐๐๐๐๐๐๐ ๐๐๐๐๐๐๐ ๐๐ ๐๐๐ ๐๐๐๐๐๐:
Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
Comprehensive quantitative and qualitative insights at segment and sub-segment level
Covid 19 impact trends and perspective
Granular insights at global/regional/country level
Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
Blanket coverage on competitive landscape
Winning imperatives
Exhaustive coverage on 'Strategic Developments' registered by leading players of the market
Contact:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Patented Drugs Market Expected to Reach $1,456.5 Billion by 2032 here
News-ID: 3269769 • Views: โฆ
More Releases from Allied Market Research
Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
The global urinary drainage bags market is experiencing robust growth, with its market size valued at $1.4billion in 2021 and projected to reach $2billion by 2031. This expansion represents a compound annual growth rate (CAGR) of 3.8% from 2021 to 2031, highlighting the increasing demand for these essential medical devices.
Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A17529
What Are Urinary Drainage Bags?
Urinary drainage bags are specialized medical devices designed to collectโฆ
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
The global cream powder industry was estimated at $4.8 billion in 2021 and is expected to hit $8.9 billion by 2031, registering a CAGR of 6.4% from 2022 to 2031.
The cream powder market is experiencing growth due to various factors, including the increasing popularity of bakeries and HoReCa (hotels, restaurants, and cafes) and rising consumer demand for natural products. The dairy-based segment is a significant contributor to the market's growthโฆ
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Bil โฆ
The global micro drone industry generated $6.71 billion in 2020, and is expected to reach $28.91 billion in 2030, witnessing a CAGR of 17.2% from 2021 to 2030. The report provides an extensive analysis of changing market dynamics, top segments, top investment pockets, regional landscape, value chain, and competitive scenario.
Increased operational efficiency and rise in demand for improved surveillance drive the growth of the global micro drone market. However, strictโฆ
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of โฆ
The global microwaveable foods industry was accounted for $120.45 billion in 2020, and is expected to reach $230.93 billion by 2031, growing at a CAGR of 5.6% from 2022 to 2031.
Rise in popularity of fast-food restaurants and large population base coupled with increase in number of quick-service restaurants drive the global microwaveable foods market. However, lack of awareness about microwavable foods hinders the market growth. On the contrary, rise inโฆ
More Releases for Patent
Spectral Capital Announces Substantial Patent Milestone; Continues Globally Comp โฆ
Image: https://www.globalnewslines.com/uploads/2025/02/1738774387.jpg
SEATTLE - Feb 5, 2025 - Spectral Capital Corporation (OTCQB: FCCN [https://www.prnewswire.com/news-releases/spectral-capital-announces-substantial-patent-milestone-continues-globally-competitive-quantum-patent-strategy-302368601.html?tc=eml_cleartime#financial-modal]), a deep quantum technology platform company, is pleased to announce the achievement of a second major patent milestone in its plan to become a globally competitive leader in quantum computing patents.
"We are proud to announce that we have filed 104 provisional patent applications in the field of quantum computing. We promised our shareholders we would have theseโฆ
iFLY/SkyVenture patent restricted by European Patent Office
Gladbeck, 21 September 2016. In the patent invalidity attack of the German manufacturer of freefall simulators, Indoor Skydiving Germany Group (ISG) against its US competitor iFLY/S Skyventure International (UK) Ltd (iFLY), the European Patent Office ruled in favor of ISG and restricted the relevant parts of iFLYยดs European Patent No. EP 2 287 073. iFly may choose to appeal this decision.
ISG, German manufacturer of high performance freefall simulators for professionalโฆ
Rebecca Klemm Issued Puzzle Patent: Polygon Puzzle and Related Methods, Patent N โฆ
NumbersAlive! is pleased to announce that its founder, Rebecca Klemm, Ph.D., received her first US utility patent on August 2nd.
The newly issued patent protects Dr. Klemmโs process of forming puzzles by decomposing shapes into smaller components with a mathematical correlation to the original. The patent additionally protects providing a base with cutouts to receive the original shapes that may be assembled from decomposed components. Finally, the patent protects the useโฆ
Patent Drafting Program
PATENT DRAFTING PROGRAM AT IIPTA
By Rachana
February 06, 2013
Delhi, Indian Institute of Patent and Trademark Attorney announces the introduction of Patent Drafting Program as one among the many Intellectual Property related programs offered by the company. This program is focussed mainly on providing an in-depth understanding and writing of patent language in an advanced level.
โฆ
Intellectual Property Law Departments decrease Patent Staff, yet Patent Efficien โฆ
ipPerformance Group, a leader in benchmarking corporate intellectual property law and management operations announces the release of its 2012 Intellectual Property Law Department study. While there was an increase in innovation activity worldwide throughout 2010 and 2011, companies reported decreased numbers of in-house IP Attorneys and IP Staff. The total IP Staff and Attorneys worldwide is down 18%; with the decrease in staff being compensated for with increased lawโฆ
ParkerVisionโs Telecom Patent Portfolio Honored Among Patent Boardโs Top 30
Wireless technology firm leads telecom sector in three of six categories
JACKSONVILLE, Fla., Jan. 20, 2012 โ ParkerVision, Inc. (Nasdaq: PRKR), a developer and marketer of semiconductor technology solutions for wireless applications, again is ranked among The Patent Boardโs top 30 strongest patent portfolios in the wireless and telecom industry, including leading the telecom sector with first place rankings in three of six scoring criteria.
The ranking is based on The Patentโฆ
